NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

This poor misguided author, Dr. Olivier, does not appear to understand crossover confoundment (randomization confoundment as a direct consequence), immunotherapeutic delayed impact, pseudoprogression, unprecedented long term survival and the ethics of denying crossover, and defers to Temodar as the gold standard when it typically achieves only 3% five year survival.

He does use googly eyes on Twitter to draw attention to his journal article. Perhaps he missed his calling.